Shanghai Sanyou Medical Co., Ltd.

Symbol: 688085.SS




Market price today

  • 77.9564

    P/E Ratio

  • 3.3781

    PEG Ratio

  • 4.08B

    MRK Cap

  • 0.00%

    DIV Yield

Shanghai Sanyou Medical Co., Ltd. (688085-SS) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Medical Devices
CEO:Dr. Mingyan Liu
Full-time employees:434
Address:Medical Apparatus Gdn of Zhangjiang Hi-T

Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and z-minimally invasive products; and trauma implants, including shoulder and elbow system, hip and pelvis system, knee system, knee system, and palm and wrist systems. Shanghai Sanyou Medical Co., Ltd. is based in Shanghai, China.

General Outlook

When we look at how much money they make before expenses, they keep 0.714% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.147%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.153%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.025% return, is a testament to Shanghai Sanyou Medical Co., Ltd.'s adeptness in optimizing resource deployment. Shanghai Sanyou Medical Co., Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.031%. Furthermore, the proficiency of Shanghai Sanyou Medical Co., Ltd. in capital utilization is underscored by a remarkable 0.027% return on capital employed.

Stock Prices

Shanghai Sanyou Medical Co., Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $16.36, while its low point bottomed out at $15.5. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Shanghai Sanyou Medical Co., Ltd.'s stock market.

Liquidity Ratios

Analyzing 688085.SS liquidity ratios reveals its financial health of the firm. The current ratio of 428.59% gauges short-term asset coverage for liabilities. The quick ratio (318.40%) assesses immediate liquidity, while the cash ratio (273.37%) indicates cash reserves.

Current Ratio428.59%
Quick Ratio318.40%
Cash Ratio273.37%

Profitability Ratios

688085.SS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 23.57% underscores its earnings before tax deductions. The effective tax rate stands at 17.45%, revealing its tax efficiency. The net income per EBT, 65.05%, and the EBT per EBIT, 160.04%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 14.73%, we grasp its operational profitability.

Pretax Profit Margin23.57%
Effective Tax Rate17.45%
Net Income per EBT65.05%
EBT per EBIT160.04%
EBIT per Revenue14.73%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 4.29, it details the span from stock purchase to revenue. The 3 days it takes to settle debts showcases its creditor relations. Meanwhile, a 3 cash conversion cycle and 474.51% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

Days of Sales Outstanding318
Days of Inventory Outstanding695
Operating Cycle771.46
Days of Payables Outstanding315
Cash Conversion Cycle456
Receivables Turnover4.75
Payables Turnover1.16
Inventory Turnover0.53
Fixed Asset Turnover1.09
Asset Turnover0.17

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.72, and free cash flow per share, 0.58, depict cash generation on a per-share basis. The cash per share value, 2.53, showcases liquidity position. A payout ratio of 0.04 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.46, offers insight into cash flow relative to sales.

Operating Cash Flow per Share0.72
Free Cash Flow per Share0.58
Cash per Share2.53
Payout Ratio0.04
Operating Cash Flow Sales Ratio0.46
Free Cash Flow to Operating Cash Flow Ratio0.81
Cash Flow Coverage Ratio3.01
Short Term Coverage Ratio3.90
Capital Expenditure Coverage Ratio5.25
Dividend Paid and Capex Coverage Ratio4.90

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 2.55%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.03, we discern the balance between debt and equity financing. The long-term debt to capitalization, 0.70%, and total debt to capitalization, 3.00%, ratios shed light on its capital structure.

Debt Ratio2.55%
Debt Equity Ratio0.03
Long Term Debt to Capitalization0.70%
Total Debt to Capitalization3.00%
Cash Flow to Debt Ratio3.01
Company Equity Multiplier1.21

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 1.83, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.38, reflects the portion of profit attributed to each share. The book value per share, 7.71, represents the net asset value distributed per share, while the tangible book value per share, 6.64, excludes intangible assets.

Revenue Per Share1.83
Net Income Per Share0.38
Book Value Per Share7.71
Tangible Book Value Per Share6.64
Shareholders Equity Per Share7.71
Interest Debt Per Share0.02
Capex Per Share-0.10

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -30.00%, indicates top-line expansion, while the gross profit growth, -40.83%, reveals profitability trends. EBIT growth, -55.70%, and operating income growth, -55.70%, offer insights into operational profitability progression. The net income growth, -49.91%, showcases bottom-line expansion, and the EPS growth, -50.65%, measures the growth in earnings per share.

Revenue Growth-30.00%
Gross Profit Growth-40.83%
EBIT Growth-55.70%
Operating Income Growth-55.70%
Net Income Growth-49.91%
EPS Growth-50.65%
EPS Diluted Growth-50.65%
Dividends per Share Growth-48.63%
Operating Cash Flow Growth72.15%
Free Cash Flow Growth1264.53%
10-Year Revenue Growth per Share359.95%
5-Year Revenue Growth per Share54.62%
3-Year Revenue Growth per Share16.38%
10-Year Operating CF Growth per Share955.47%
5-Year Operating CF Growth per Share926.54%
3-Year Operating CF Growth per Share246.38%
10-Year Net Income Growth per Share2227.50%
5-Year Net Income Growth per Share16.37%
3-Year Net Income Growth per Share-19.38%
10-Year Shareholders Equity Growth per Share823.15%
5-Year Shareholders Equity Growth per Share325.81%
3-Year Shareholders Equity Growth per Share24.88%
5-Year Dividend per Share Growth per Share34.73%
Receivables Growth-70.69%
Inventory Growth13.91%
Asset Growth3.20%
Book Value per Share Growth4.16%
Debt Growth-7.43%
R&D Expense Growth-3.89%
SGA Expenses Growth-43.36%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 4,195,477,030.5, captures the company's total value, considering both debt and equity. Income quality, 2.81, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.03, gauges operational efficiency, while the research and development to revenue, 12.77%, highlights investment in innovation. The ratio of intangibles to total assets, 17.73%, indicates the value of non-physical assets, and capex to operating cash flow, -9.66%, measures reinvestment capability.

Enterprise Value4,195,477,030.5
Income Quality2.81
Sales General and Administrative to Revenue0.03
Research and Development to Revenue12.77%
Intangibles to Total Assets17.73%
Capex to Operating Cash Flow-9.66%
Capex to Revenue-5.71%
Capex to Depreciation-47.70%
Graham Number8.17
Return on Tangible Assets5.14%
Graham Net Net2.47
Working Capital751,852,525
Tangible Asset Value1,648,498,816
Net Current Asset Value734,193,570
Average Receivables184,613,692.5
Average Payables122,754,441
Average Inventory165,874,017
Days Sales Outstanding67
Days Payables Outstanding340
Days of Inventory On Hand597

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.39, and the price to book ratio, 2.39, reflect the market's valuation relative to the company's book value. The price to sales ratio, 11.95, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 31.86, and price to operating cash flows, 25.79, gauge market valuation against cash flow metrics.

Price Book Value Ratio2.39
Price to Book Ratio2.39
Price to Sales Ratio11.95
Price Cash Flow Ratio25.79
Price Earnings to Growth Ratio3.38
Enterprise Value Multiple64.10
Price Fair Value2.39
Price to Operating Cash Flow Ratio25.79
Price to Free Cash Flows Ratio31.86
Price to Tangible Book Ratio2.53
Enterprise Value to Sales9.23
Enterprise Value Over EBITDA26.91
EV to Operating Cash Flow15.62
Earnings Yield1.97%
Free Cash Flow Yield5.01%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Shanghai Sanyou Medical Co., Ltd. (688085.SS) on the SHH in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 77.956 in 2024.

What is the ticker symbol of Shanghai Sanyou Medical Co., Ltd. stock?

The ticker symbol of Shanghai Sanyou Medical Co., Ltd. stock is 688085.SS.

What is company IPO date?

IPO date of Shanghai Sanyou Medical Co., Ltd. is 2020-04-09.

What is company current share price?

Current share price is 16.440 CNY.

What is stock market cap today?

The market cap of stock today is 4084583760.000.

What is PEG ratio in 2024?

The current 3.378 is 3.378 in 2024.

What is the number of employees in 2024?

In 2024 the company has 434.